Sheng-Hao Lin

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Particulate matter of 2.5 μm or less in diameter disturbs the balance of TH17/regulatory T cells by targeting glutamate oxaloacetate transaminase 1 and hypoxia-inducible factor 1α in an asthma model

Licheng Sun, Jinrong Fu, Sheng-Hao Lin et al. · Journal of Allergy and Clinical Immunology · 2019 · 124 citations

Life Sciences, Immunology, Physiology +15

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

Synergistic Anticancer Effect of a Combination of Paclitaxel and 5-Demethylnobiletin Against Lung Cancer Cell Line In Vitro and In Vivo

Kok‐Tong Tan, Shiming Li, Yi Rong Li et al. · Applied Biochemistry and Biotechnology · 2018 · 26 citations

Medicine, Oncology, Pharmacology +12

Novel App-Based Portable Spirometer for the Early Detection of COPD

Ching‐Hsiung Lin, Shih-Lung Cheng, Hao‐Chien Wang et al. · Diagnostics · 2021 · 16 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16